Clinical trial

Metabolic Syndrome in PCOS: Precursors and Interventions

NCT00442689 · Northwestern University, Other · Completed

Key facts

NCT number NCT00442689
Title Metabolic Syndrome in PCOS: Precursors and Interventions
Official title Metabolic Syndrome in PCOS: Precursors and Interventions
Lead sponsor Northwestern University, Other
Collaborators National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH
Status Completed
Study type Interventional
Conditions Polycystic Ovary Syndrome, Metabolic Syndrome
Intervention type Drug, Other
Interventions flutamide, ethinyl estradiol 35 mcg and drospirenone 3 mg, placebo
Enrollment 97
Start date Jul 1, 2006
Primary completion Nov 1, 2012
Completion Nov 1, 2012
First posted Mar 2, 2007
Last update posted Jun 6, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies